GWCM
Godshalk Welsh Capital Management Portfolio holdings
AUM
$162M
This Quarter Return
+5.53%
1 Year Return
+14.73%
3 Year Return
+54.87%
5 Year Return
+105.33%
10 Year Return
+267.23%
AUM
$144M
AUM Growth
+$144M
(+5.8%)
Cap. Flow
+$3.96M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
29.15%
Holding
116
New
5
Increased
34
Reduced
40
Closed
2
Top Buys
| 1 |
Vanguard Intermediate-Term Bond ETF
BIV
|
$2.68M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
$777K |
| 3 |
Invesco QQQ Trust
QQQ
|
$543K |
| 4 |
Cigna
CI
|
$538K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$304K |
Top Sells
| 1 |
AT&T
T
|
$497K |
| 2 |
GSK
GSK
|
$338K |
| 3 |
NeoGenomics
NEO
|
$215K |
| 4 |
Microsoft
MSFT
|
$118K |
| 5 |
Globus Medical
GMED
|
$99.3K |
Sector Composition
| 1 | Technology | 20.02% |
| 2 | Healthcare | 13.14% |
| 3 | Financials | 12.8% |
| 4 | Consumer Staples | 10.28% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Invesco QQQ Trust
QQQ
$361B
| $543K | 0.38% |
+1,700
| New | +$543K |
|
77
MetLife
MET
$53.2B
| $541K | 0.38% |
8,900
+400
| +5% | +$24.3K |
|
|
78
Cigna
CI
$81.2B
| $538K | 0.37% |
+2,227
| New | +$538K |
|
79
Quest Diagnostics
DGX
$20.3B
| $526K | 0.37% |
4,100
-150
| -4% | -$19.2K |
|
80
UGI
UGI
$7.37B
| $478K | 0.33% |
11,650
+600
| +5% | +$24.6K |
|
81
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.58B
| $474K | 0.33% |
7,500
+2,050
| +38% | +$130K |
|
82
Lockheed Martin
LMT
$105B
| $471K | 0.33% |
1,275
| – | – |
|
83
Masco
MAS
$15.1B
| $467K | 0.33% |
7,800
| – | – |
|
84
3M
MMM
$81.8B
| $464K | 0.32% |
2,410
| – | – |
|
85
WideOpenWest
WOW
$437M
| $462K | 0.32% |
34,000
| – | – |
|
86
Abbott
ABT
$230B
| $455K | 0.32% |
3,800
+300
| +9% | +$35.9K |
|
|
87
AT&T
T
$210B
| $442K | 0.31% |
14,587
-16,400
| -53% | -$497K |
|
88
Consolidated Edison
ED
$35.2B
| $423K | 0.29% |
5,650
| – | – |
|
89
eBay
EBAY
$41.2B
| $410K | 0.29% |
6,700
| – | – |
|
90
Vanguard Tax-Exempt Bond Index Fund
VTEB
$37.9B
| $383K | 0.27% |
7,000
+2,000
| +40% | +$109K |
|
91
Citigroup
C
$173B
| $376K | 0.26% |
5,175
| – | – |
|
92
Danaher
DHR
$145B
| $371K | 0.26% |
1,650
| – | – |
|
93
iShares Core Moderate Allocation ETF
AOM
$1.57B
| $370K | 0.26% |
8,500
+125
| +1% | +$5.44K |
|
94
Bristol-Myers Squibb
BMY
$97B
| $366K | 0.26% |
5,800
-200
| -3% | -$12.6K |
|
95
iShares Core S&P US Growth ETF
IUSG
$24.1B
| $340K | 0.24% |
3,750
+350
| +10% | +$31.7K |
|
96
Mastercard
MA
$533B
| $338K | 0.24% |
950
| – | – |
|
97
Hershey
HSY
$37.5B
| $332K | 0.23% |
2,100
| – | – |
|
|
98
GSK
GSK
$79.2B
| $327K | 0.23% |
9,150
-9,450
| -51% | -$338K |
|
99
BHP
BHP
$140B
| $326K | 0.23% |
4,700
| – | – |
|
100
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.5B
| $309K | 0.22% |
5,650
| – | – |
|